Desitin is active in CNS Indications with focus on epilepsy and Parkinsons’s diseases. But Desitin’s portfolio also includes products for the treatment of psychiatric diseases, e.g. psychosis and depression as well as orphan indications such as Huntington’s disease or Dravet Syndrome.
Epilepsy – a chronic disease affecting about 0,5-1% of the total population in Europe needs an individualized therapy with antiepileptic drugs. Patients are suffering from different types of epileptic seizures. more
Parkinsons’s disease – a chronic degenerative disorder of the central nervous system normally affecting elderly patients also needs an individualized and stage-adapted medical treatment. more